Lack of an Association Between Spleen Volume and Risk of Pneumococcal Infection in Cancer Patients: a Nested Case-control Study

Overview

Journal BMC Infect Dis

Publisher Biomed Central

Specialty Infectious Diseases

Date 2024 Dec 19

PMID 39696050

Authors

Ibuki Kurihara

Hajime Yamazaki

Sakura Kato

Noriko Oyama-Manabe

Hitoshi Sugawara

Affiliations

Soon will be listed here.

Abstract

Background: The spleen is a key organ in preventing pneumococcal infection, especially in patients with immunocompromised condition such as those with cancer. Previous studies have shown that a small spleen volume in pneumococcal pneumonia patients is associated with severe disease course. However, it is unknown whether a small spleen increases risk of pneumococcal infection. We investigated the association between spleen volume and risk of pneumococcal infection.

Methods: This study was a retrospective cohort study using a nested case-control design and involved adult patients with malignancy who underwent chest and/or abdominal CT scans from January 1, 2008, to September 30, 2020, at a tertiary care center in Japan. Exclusion criteria comprised patients diagnosed with hepatic cirrhosis, leukemia, lymphoma, and/or post-splenectomy. From the cohort group that met all selection criteria (n = 22475), we identified all incident cases of pneumococcal infection (pneumococcal pneumonia and/or invasive pneumococcal diseases) and matched them with four controls by age, sex, and follow-up duration. Odds ratios (ORs) for the association between spleen volume and pneumococcal infection were estimated using conditional logistic regression models adjusted for body surface area, performance status, Charlson comorbidity index, and metastatic cancer.

Results: The median spleen volume was 85.8 (interquartile range, 65.8-120.8) cm. Over a median follow-up of 4.95 (interquartile range, 1.54-9.25) years, 60 patients were diagnosed with pneumococcal infection (20 with invasive pneumococcal disease and 40 with pneumonia without invasive pneumococcal disease) and matched with 240 controls. Spleen volume reduction (per 10 cm) did not increase risk of pneumococcal infection in a crude analysis [OR 1.04 (95% CI 0.98-1.11)]. The outcome remained unchanged in the multivariable analysis (OR 1.01 [95% CI 0.95-1.08]).

Conclusions: Small spleen volume did not increase risk of pneumococcal infection in cancer patients.

References

Hiraiwa H, Okumura T, Sawamura A, Kondo T, Kazama S, Kimura Y . Association between splenic volume and pulsatility index in patients with left ventricular assist devices. Int J Artif Organs. 2020; 44(4):282-287. DOI: 10.1177/0391398820957019. View

Ma J . Breath-hold water and fat imaging using a dual-echo two-point Dixon technique with an efficient and robust phase-correction algorithm. Magn Reson Med. 2004; 52(2):415-9. DOI: 10.1002/mrm.20146. View

Sauer J, Sobolewski K, Dommisch K . Splenic metastases--not a frequent problem, but an underestimate location of metastases: epidemiology and course. J Cancer Res Clin Oncol. 2008; 135(5):667-71. DOI: 10.1007/s00432-008-0502-3. View

Maruyama T, Taguchi O, Niederman M, Morser J, Kobayashi H, Kobayashi T . Efficacy of 23-valent pneumococcal vaccine in preventing pneumonia and improving survival in nursing home residents: double blind, randomised and placebo controlled trial. BMJ. 2010; 340:c1004. PMC: 2834887. DOI: 10.1136/bmj.c1004. View

van der Poll T, Opal S . Pathogenesis, treatment, and prevention of pneumococcal pneumonia. Lancet. 2009; 374(9700):1543-56. DOI: 10.1016/S0140-6736(09)61114-4. View

Kyaw M, Rose Jr C, Fry A, Singleton J, Moore Z, Zell E . The influence of chronic illnesses on the incidence of invasive pneumococcal disease in adults. J Infect Dis. 2005; 192(3):377-86. DOI: 10.1086/431521. View

Suzuki M, Dhoubhadel B, Ishifuji T, Yasunami M, Yaegashi M, Asoh N . Serotype-specific effectiveness of 23-valent pneumococcal polysaccharide vaccine against pneumococcal pneumonia in adults aged 65 years or older: a multicentre, prospective, test-negative design study. Lancet Infect Dis. 2017; 17(3):313-321. DOI: 10.1016/S1473-3099(17)30049-X. View

Koga Y, Fujita M, Nakahara T, Yagi T, Miyauchi T, Kaneda K . Splenic volume in severe sepsis is associated with disease severity and pneumococcal infection. Acute Med Surg. 2017; 3(4):339-344. PMC: 5667317. DOI: 10.1002/ams2.204. View

Mitsuyama Y, Shimizu K, Hirayama A, Komukai S, Kitamura T, Ogura H . Splenic volume on computed tomography scans is associated with mortality in patients with sepsis. Int J Infect Dis. 2021; 104:624-630. DOI: 10.1016/j.ijid.2021.01.012. View

10.

Yu V, Chiou C, Feldman C, Ortqvist A, Rello J, Morris A . An international prospective study of pneumococcal bacteremia: correlation with in vitro resistance, antibiotics administered, and clinical outcome. Clin Infect Dis. 2003; 37(2):230-7. DOI: 10.1086/377534. View

11.

Essebag V, Platt R, Abrahamowicz M, Pilote L . Comparison of nested case-control and survival analysis methodologies for analysis of time-dependent exposure. BMC Med Res Methodol. 2005; 5(1):5. PMC: 548149. DOI: 10.1186/1471-2288-5-5. View

12.

Anai S, Ibusuki R, Takao T, Okushima K, Sakurai Y, Hisasue J . Splenic volume in pneumococcal pneumonia patients is associated with disease severity and mortality. J Infect Chemother. 2020; 26(9):977-985. DOI: 10.1016/j.jiac.2020.04.023. View

13.

Di Sabatino A, Carsetti R, Corazza G . Post-splenectomy and hyposplenic states. Lancet. 2011; 378(9785):86-97. DOI: 10.1016/S0140-6736(10)61493-6. View

14.

Breiman R, Beck J, Korobkin M, Glenny R, Akwari O, Heaston D . Volume determinations using computed tomography. AJR Am J Roentgenol. 1982; 138(2):329-33. DOI: 10.2214/ajr.138.2.329. View

15.

Oken M, Creech R, Tormey D, Horton J, Davis T, McFadden E . Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol. 1982; 5(6):649-55. View

16.

Corazza G, Tarozzi C, Vaira D, Frisoni M, Gasbarrini G . Return of splenic function after splenectomy: how much tissue is needed?. Br Med J (Clin Res Ed). 1984; 289(6449):861-4. PMC: 1443415. DOI: 10.1136/bmj.289.6449.861. View

17.

Waight P, Andrews N, Ladhani S, Sheppard C, Slack M, Miller E . Effect of the 13-valent pneumococcal conjugate vaccine on invasive pneumococcal disease in England and Wales 4 years after its introduction: an observational cohort study. Lancet Infect Dis. 2015; 15(5):535-43. DOI: 10.1016/S1473-3099(15)70044-7. View

18.

Haddy F, Scott J, MOLNAR J . MECHANISM OF VOLUME REPLACEMENT AND VASCULAR CONSTRICTION FOLLOWING HEMORRHAGE. Am J Physiol. 1965; 208:169-81. DOI: 10.1152/ajplegacy.1965.208.1.169. View

19.

Talbot T, Hartert T, Mitchel E, Halasa N, Arbogast P, Poehling K . Asthma as a risk factor for invasive pneumococcal disease. N Engl J Med. 2005; 352(20):2082-90. DOI: 10.1056/NEJMoa044113. View

20.

Okuma H, Gonoi W, Ishida M, Shirota G, Kanno S, Shintani Y . Comparison of volume and attenuation of the spleen between postmortem and antemortem computed tomography. Int J Legal Med. 2016; 130(4):1081-1087. DOI: 10.1007/s00414-016-1337-0. View